Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cells.
The outcome for patients with advanced metastatic and recurrent prostate cancer is still poor. Therefore, new chemotherapeutics are required, especially for killing cancer stem cells that are thought to be responsible for disease recurrence. In this study, we screened the effect of a novel palladium...
Main Authors: | Engin Ulukaya, Fiona M Frame, Buse Cevatemre, Davide Pellacani, Hannah Walker, Vincent M Mann, Matthew S Simms, Michael J Stower, Veysel T Yilmaz, Norman J Maitland |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3651166?pdf=render |
Similar Items
-
Overexpression of Placental Growth Factor in Stromal Cells from Benign Prostatic Hyperplasia: Another Piece in the Puzzle?
by: Conor M. Devlin, et al.
Published: (2020-10-01) -
Epigenetic Control of Gene Expression in the Normal and Malignant Human Prostate: A Rapid Response Which Promotes Therapeutic Resistance
by: Fiona M. Frame, et al.
Published: (2019-05-01) -
Low Temperature Plasma: A Novel Focal Therapy for Localized Prostate Cancer?
by: Adam M. Hirst, et al.
Published: (2014-01-01) -
Prostate, benign hypertrophy and prostatic carcinoma - a study of cell biology of prostate and chemotherapy for prostatic hypertrophy and prostatic cancer /
by: Chang, Ching-Jey George
Published: (1994) -
Cytotoxic effects of juglone and Pterocarya fraxinifolia on prostate cancer cells
by: Morteza Mahdavi, et al.
Published: (2019-01-01)